Novel secondary mutations C56S and G149A confer resistance to HIV-1 integrase strand transfer inhibitors-Reference-Cited by-同舟云学术

Novel secondary mutations C56S and G149A confer resistance to HIV-1 integrase strand transfer inhibitors

Published:2018-04 Issue: Volume:152 Page:1-9
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Yoshinaga Tomokazu,Seki Takahiro,Miki Shigeru,Miyamoto Tadashi,Suyama-Kagitani Akemi,Kawauchi-Miki Shinobu,Kobayashi Masanori,Sato Akihiko^ORCID,Stewart Eugene,Underwood Mark,Fujiwara Tamio

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference22 articles.

1. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone;Adachi;J. Virol.,1986

2. HIV drug resistance against strand transfer integrase inhibitors;Anstett;Retrovirology,2017

3. Dolutegravir interactions with HIV-1 integrase-DNA: structural rationale for drug resistance and dissociation kinetics;DeAnda;PLoS One,2013

4. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral;Garvey;Antimicrob. Agents Chemother.,2008

5. The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity;Greenwald;Biochemistry,1999

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive database of HIV mutations selected during antiretroviral in vitro passage experiments;Antiviral Research;2024-10

2. Comprehensive Database of HIV Mutations Selected During Antiretroviral in Vitro Passage Experiments;2024

3. The Effect of Treatment-Associated Mutations on HIV Replication and Transmission Cycles;Viruses;2022-12-30

4. Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir;Antiviral Research;2022-12

5. Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?;Current HIV/AIDS Reports;2022-09-16